How a dad turned his daughter's cerebral palsy into not one but two products for movement disorders. Now, the San Francisco ...
People with MS experience significant changes in cognition more than a year before significant physical decline is evident, a ...
The MIND diet significantly reduces disability and fatigue, improving quality of life for people with MS, a long-term study ...
18hon MSN
Menopause linked to distinct differences in multiple sclerosis presentation and comorbidities
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
Higher intake of ultra-processed foods (UPFs) may exacerbate disease activity in early multiple sclerosis (MS), according to ...
Major revisions to the diagnostic criteria for neuromyelitis optica spectrum disorder will broaden their scope to related syndromes and have a substantial clinical impact.
Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black individuals.
News-Medical.Net on MSN
Menopause Found to shape initial symptoms and comorbidities in multiple sclerosis
New research presented today at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple SclerosisAcross non-active progressive MS (primary progressive and secondary ...
The Hearty Soul on MSN
Study Points to Two Bacteria as Possible Causes of Multiple Sclerosis
Until now, Multiple Sclerosis has been a disease that has baffled scientists and doctors. New research, however, is pointing to a surprising potential cause of Multiple Sclerosis (MS): two specific ...
Terray Therapeutics, an AI-native biotechnology company, appoints veteran drug discovery expert Wendy Young, Ph.D., to its ...
News-Medical.Net on MSN
Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results